For patients with moderately to severely active ulcerative colitis, oral icotrokinra, a peptide that blocks the ...

In a world-first international trial, adding intismeran, a type of personalized therapeutic cancer vaccine made from each ...

Prostate cancer is the most common cancer in men—in 2013, it affected more than 1 million men across the world. The cancer ...

Pancreatic cancer is one of the most aggressive and difficult-to-treat cancers. One reason for its resistance to therapy is ...

The phase 2 BESTOW clinical trial showed that tegoprubart (a novel anti-CD40L antibody therapy) was better at preserving ...

New research indicates that U.S.–Mexico border counties experience disproportionately elevated rates of death from chronic ...

New research indicates that commonly used measures of kidney function underestimate the prevalence of chronic kidney disease ...

Research published today identifies potential new ways to treat the most common type of colorectal cancer in Ireland. The ...

For years, developers of virtual reality (VR) and augmented reality (AR) technologies have worked to address an unwanted side ...

Scientists at Trinity College Dublin have made a breakthrough in understanding how cancer cells can evade the cell-killing ...

The activity of six different genes can help determine survival in patients with acute myeloid leukemia (AML), according to a ...

Early results of the first clinical trial to evaluate the drug invikafusp alfa (invika) in humans indicate that the treatment ...